Co-existence of BRAF and NRAS driver mutations in the same melanoma cells results in heterogeneity of targeted therapy resistance. (Q36176934)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Co-existence of BRAF and NRAS driver mutations in the same melanoma cells results in heterogeneity of targeted therapy resistance. |
scientific article |
Statements
Co-existence of BRAF and NRAS driver mutations in the same melanoma cells results in heterogeneity of targeted therapy resistance (English)
Marieke I G Raaijmakers
Daniel S Widmer
Apurva Narechania
Ossia Eichhoff
Sandra N Freiberger
Judith Wenzina
Daniela Mihic-Probst